These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 14632770)

  • 21. Severe cardiopulmonary complications consistent with systemic inflammatory response syndrome caused by leukemia cell lysis in childhood acute myelomonocytic or monocytic leukemia.
    Hijiya N; Metzger ML; Pounds S; Schmidt JE; Razzouk BI; Rubnitz JE; Howard SC; Nunez CA; Pui CH; Ribeiro RC
    Pediatr Blood Cancer; 2005 Jan; 44(1):63-9. PubMed ID: 15368547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute leukaemia in children--French-American-British (FAB) classification and its relation to clinical features.
    Hassan K; Bukhari KP; Zafar A; Malik MZ; Akhtar MJ
    J Pak Med Assoc; 1992 Feb; 42(2):29-31. PubMed ID: 1573762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distinct lysozyme content in different subtypes of acute myeloid leukaemic cells: an ultrastructural immunogold study.
    Resnitzky P; Shaft D
    Br J Haematol; 1994 Oct; 88(2):357-63. PubMed ID: 7803282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Childhood acute myeloblastic leukemias. Report of 21 cases].
    Laatiri MA; Chehata S; Amouri A; Bouaouina N; Chatti S; Saad A; Ennabli S
    Tunis Med; 2000 Mar; 78(3):167-71. PubMed ID: 11026819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro drug resistance profiles of adult versus childhood acute lymphoblastic leukaemia.
    Styczynski J; Pieters R; Huismans DR; Schuurhuis GJ; Wysocki M; Veerman AJ
    Br J Haematol; 2000 Sep; 110(4):813-8. PubMed ID: 11054062
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Altered expression of CD45 isoforms in differentiation of acute myeloid leukemia.
    Miyachi H; Tanaka Y; Gondo K; Kawada T; Kato S; Sasao T; Hotta T; Oshima S; Ando Y
    Am J Hematol; 1999 Nov; 62(3):159-64. PubMed ID: 10539882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell proliferation is related to in vitro drug resistance in childhood acute leukaemia.
    Kaaijk P; Kaspers GJ; Van Wering ER; Broekema GJ; Loonen AH; Hählen K; Schmiegelow K; Janka-Schaub GE; Henze G; Creutzig U; Veerman AJ
    Br J Cancer; 2003 Mar; 88(5):775-81. PubMed ID: 12618889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined analysis of differentiation inhibitory factor nm23-H1 and nm23-H2 as prognostic factors in acute myeloid leukaemia.
    Wakimoto N; Yokoyama A; Okabe-Kado J; Nagata N; Motoyoshi K; Honma Y
    Br J Cancer; 1998 Jun; 77(12):2298-303. PubMed ID: 9649149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytogenetic abnormalities and monosomal karyotypes in children and adolescents with acute myeloid leukemia: correlations with clinical characteristics and outcome.
    Manola KN; Panitsas F; Polychronopoulou S; Daraki A; Karakosta M; Stavropoulou C; Avgerinou G; Hatzipantelis E; Pantelias G; Sambani C; Pagoni M
    Cancer Genet; 2013 Mar; 206(3):63-72. PubMed ID: 23411131
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pegylated asparaginase (Oncaspar) in children with ALL: drug monitoring in reinduction according to the ALL/NHL-BFM 95 protocols.
    Müller HJ; Löning L; Horn A; Schwabe D; Gunkel M; Schrappe M; von Schütz V; Henze G; Casimiro da Palma J; Ritter J; Pinheiro JP; Winkelhorst M; Boos J
    Br J Haematol; 2000 Aug; 110(2):379-84. PubMed ID: 10971395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intravenous pegylated asparaginase versus intramuscular native Escherichia coli L-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial.
    Place AE; Stevenson KE; Vrooman LM; Harris MH; Hunt SK; O'Brien JE; Supko JG; Asselin BL; Athale UH; Clavell LA; Cole PD; Kelly KM; Laverdiere C; Leclerc JM; Michon B; Schorin MA; Welch JJ; Lipshultz SE; Kutok JL; Blonquist TM; Neuberg DS; Sallan SE; Silverman LB
    Lancet Oncol; 2015 Dec; 16(16):1677-90. PubMed ID: 26549586
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional response of leukaemic blasts to stromal cell-derived factor-1 correlates with preferential expression of the chemokine receptor CXCR4 in acute myelomonocytic and lymphoblastic leukaemia.
    Möhle R; Schittenhelm M; Failenschmid C; Bautz F; Kratz-Albers K; Serve H; Brugger W; Kanz L
    Br J Haematol; 2000 Sep; 110(3):563-72. PubMed ID: 10997965
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The immunophenotype of adult acute myeloid leukemia: high frequency of lymphoid antigen expression and comparison of immunophenotype, French-American-British classification, and karyotypic abnormalities.
    Khalidi HS; Medeiros LJ; Chang KL; Brynes RK; Slovak ML; Arber DA
    Am J Clin Pathol; 1998 Feb; 109(2):211-20. PubMed ID: 9583894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monitoring of asparaginase activity and asparagine levels in children on different asparaginase preparations.
    Boos J; Werber G; Ahlke E; Schulze-Westhoff P; Nowak-Göttl U; Würthwein G; Verspohl EJ; Ritter J; Jürgens H
    Eur J Cancer; 1996 Aug; 32A(9):1544-50. PubMed ID: 8911116
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vascular endothelial growth factor secretion is an independent prognostic factor for relapse-free survival in pediatric acute myeloid leukemia patients.
    de Bont ES; Fidler V; Meeuwsen T; Scherpen F; Hählen K; Kamps WA
    Clin Cancer Res; 2002 Sep; 8(9):2856-61. PubMed ID: 12231527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD117 (c-kit) is a restricted antigen of acute myeloid leukemia and characterizes early differentiative levels of M5 FAB subtype.
    Cascavilla N; Musto P; D'Arena G; Melillo L; Carella AM; Petrilli MP; Sanpaolo G; Carotenuto M
    Haematologica; 1998 May; 83(5):392-7. PubMed ID: 9658721
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic profile of leukemia cells influences treatment efficacy of L-asparaginase.
    Hlozkova K; Pecinova A; Alquezar-Artieda N; Pajuelo-Reguera D; Simcikova M; Hovorkova L; Rejlova K; Zaliova M; Mracek T; Kolenova A; Stary J; Trka J; Starkova J
    BMC Cancer; 2020 Jun; 20(1):526. PubMed ID: 32503472
    [TBL] [Abstract][Full Text] [Related]  

  • 38. L-asparaginase in treatment of acute leukemia in children.
    Misíková Z; Cáp J
    Neoplasma; 1978; 25(1):133-9. PubMed ID: 273152
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Leukaemia cases in Central Hospital, Riyadh (Saudi Arabia).
    Khan MQ; Shivarudrappa AS; el-Bialy S; al-Khawagi MZ; al-Mofarreh M
    J Indian Med Assoc; 1991 Feb; 89(2):38-42. PubMed ID: 2056174
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Asparaginase Therapy in Pediatric Acute Lymphoblastic Leukemia: A Focus on the Mode of Drug Resistance.
    Chen SH
    Pediatr Neonatol; 2015 Oct; 56(5):287-93. PubMed ID: 25603726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.